nodes	percent_of_prediction	percent_of_DWPC	metapath
Clevidipine—BCHE—Cisplatin—testicular cancer	0.215	0.229	CbGbCtD
Clevidipine—CYP2C19—Ifosfamide—testicular cancer	0.139	0.148	CbGbCtD
Clevidipine—CYP2C9—Ifosfamide—testicular cancer	0.116	0.123	CbGbCtD
Clevidipine—CYP2E1—Etoposide—testicular cancer	0.106	0.113	CbGbCtD
Clevidipine—CYP3A4—Ifosfamide—testicular cancer	0.0673	0.0715	CbGbCtD
Clevidipine—CYP1A2—Etoposide—testicular cancer	0.0614	0.0652	CbGbCtD
Clevidipine—CYP2C9—Cisplatin—testicular cancer	0.0563	0.0598	CbGbCtD
Clevidipine—CYP2D6—Vinblastine—testicular cancer	0.0561	0.0596	CbGbCtD
Clevidipine—CYP3A4—Vinblastine—testicular cancer	0.0357	0.0379	CbGbCtD
Clevidipine—CYP2D6—Doxorubicin—testicular cancer	0.0345	0.0366	CbGbCtD
Clevidipine—CYP3A4—Etoposide—testicular cancer	0.0321	0.0342	CbGbCtD
Clevidipine—CYP3A4—Doxorubicin—testicular cancer	0.0219	0.0233	CbGbCtD
Clevidipine—Ileus—Vinblastine—testicular cancer	0.00439	0.0748	CcSEcCtD
Clevidipine—Ileus—Ifosfamide—testicular cancer	0.00317	0.054	CcSEcCtD
Clevidipine—Renal failure acute—Chlorambucil—testicular cancer	0.00267	0.0454	CcSEcCtD
Clevidipine—Renal failure acute—Ifosfamide—testicular cancer	0.00176	0.03	CcSEcCtD
Clevidipine—Atrial fibrillation—Ifosfamide—testicular cancer	0.00172	0.0293	CcSEcCtD
Clevidipine—Acute coronary syndrome—Vinblastine—testicular cancer	0.00171	0.0292	CcSEcCtD
Clevidipine—Myocardial infarction—Vinblastine—testicular cancer	0.0017	0.029	CcSEcCtD
Clevidipine—Renal failure acute—Cisplatin—testicular cancer	0.00152	0.0259	CcSEcCtD
Clevidipine—Acute coronary syndrome—Bleomycin—testicular cancer	0.00145	0.0246	CcSEcCtD
Clevidipine—Myocardial infarction—Bleomycin—testicular cancer	0.00144	0.0245	CcSEcCtD
Clevidipine—Ileus—Epirubicin—testicular cancer	0.0014	0.0239	CcSEcCtD
Clevidipine—Ileus—Doxorubicin—testicular cancer	0.0013	0.0221	CcSEcCtD
Clevidipine—Acute coronary syndrome—Ifosfamide—testicular cancer	0.00124	0.0211	CcSEcCtD
Clevidipine—Myocardial infarction—Ifosfamide—testicular cancer	0.00123	0.0209	CcSEcCtD
Clevidipine—Acute coronary syndrome—Cisplatin—testicular cancer	0.00107	0.0182	CcSEcCtD
Clevidipine—Myocardial infarction—Cisplatin—testicular cancer	0.00106	0.0181	CcSEcCtD
Clevidipine—Acute coronary syndrome—Etoposide—testicular cancer	0.000977	0.0166	CcSEcCtD
Clevidipine—Myocardial infarction—Etoposide—testicular cancer	0.000971	0.0165	CcSEcCtD
Clevidipine—Hypersensitivity—Chlorambucil—testicular cancer	0.000891	0.0152	CcSEcCtD
Clevidipine—Hypotension—Bleomycin—testicular cancer	0.000875	0.0149	CcSEcCtD
Clevidipine—Dyspnoea—Bleomycin—testicular cancer	0.000835	0.0142	CcSEcCtD
Clevidipine—Renal failure acute—Methotrexate—testicular cancer	0.000834	0.0142	CcSEcCtD
Clevidipine—Hypersensitivity—Vinblastine—testicular cancer	0.000817	0.0139	CcSEcCtD
Clevidipine—Renal failure acute—Epirubicin—testicular cancer	0.000781	0.0133	CcSEcCtD
Clevidipine—Vomiting—Chlorambucil—testicular cancer	0.000769	0.0131	CcSEcCtD
Clevidipine—Hypotension—Ifosfamide—testicular cancer	0.000748	0.0127	CcSEcCtD
Clevidipine—Renal failure acute—Doxorubicin—testicular cancer	0.000722	0.0123	CcSEcCtD
Clevidipine—Nausea—Chlorambucil—testicular cancer	0.000718	0.0122	CcSEcCtD
Clevidipine—Dyspnoea—Ifosfamide—testicular cancer	0.000713	0.0122	CcSEcCtD
Clevidipine—Vomiting—Vinblastine—testicular cancer	0.000705	0.012	CcSEcCtD
Clevidipine—Headache—Vinblastine—testicular cancer	0.000694	0.0118	CcSEcCtD
Clevidipine—Hypersensitivity—Bleomycin—testicular cancer	0.00069	0.0117	CcSEcCtD
Clevidipine—Tachycardia—Cisplatin—testicular cancer	0.000673	0.0115	CcSEcCtD
Clevidipine—Nausea—Vinblastine—testicular cancer	0.000658	0.0112	CcSEcCtD
Clevidipine—Hypotension—Cisplatin—testicular cancer	0.000645	0.011	CcSEcCtD
Clevidipine—Hypersensitivity—Dactinomycin—testicular cancer	0.000643	0.011	CcSEcCtD
Clevidipine—Tachycardia—Etoposide—testicular cancer	0.000617	0.0105	CcSEcCtD
Clevidipine—Dyspnoea—Cisplatin—testicular cancer	0.000615	0.0105	CcSEcCtD
Clevidipine—Vomiting—Bleomycin—testicular cancer	0.000595	0.0101	CcSEcCtD
Clevidipine—Hypotension—Etoposide—testicular cancer	0.00059	0.0101	CcSEcCtD
Clevidipine—Hypersensitivity—Ifosfamide—testicular cancer	0.000589	0.01	CcSEcCtD
Clevidipine—Dyspnoea—Etoposide—testicular cancer	0.000563	0.0096	CcSEcCtD
Clevidipine—Nausea—Bleomycin—testicular cancer	0.000556	0.00947	CcSEcCtD
Clevidipine—Vomiting—Dactinomycin—testicular cancer	0.000555	0.00946	CcSEcCtD
Clevidipine—Nausea—Dactinomycin—testicular cancer	0.000519	0.00883	CcSEcCtD
Clevidipine—Vomiting—Ifosfamide—testicular cancer	0.000509	0.00867	CcSEcCtD
Clevidipine—Hypersensitivity—Cisplatin—testicular cancer	0.000508	0.00866	CcSEcCtD
Clevidipine—Nausea—Ifosfamide—testicular cancer	0.000475	0.0081	CcSEcCtD
Clevidipine—Hypersensitivity—Etoposide—testicular cancer	0.000466	0.00793	CcSEcCtD
Clevidipine—Vomiting—Cisplatin—testicular cancer	0.000439	0.00747	CcSEcCtD
Clevidipine—Nausea—Cisplatin—testicular cancer	0.00041	0.00698	CcSEcCtD
Clevidipine—Vomiting—Etoposide—testicular cancer	0.000402	0.00684	CcSEcCtD
Clevidipine—Headache—Etoposide—testicular cancer	0.000396	0.00674	CcSEcCtD
Clevidipine—Nausea—Etoposide—testicular cancer	0.000375	0.00639	CcSEcCtD
Clevidipine—Hypotension—Methotrexate—testicular cancer	0.000354	0.00602	CcSEcCtD
Clevidipine—Tachycardia—Epirubicin—testicular cancer	0.000346	0.00589	CcSEcCtD
Clevidipine—Dyspnoea—Methotrexate—testicular cancer	0.000337	0.00575	CcSEcCtD
Clevidipine—Hypotension—Epirubicin—testicular cancer	0.000331	0.00564	CcSEcCtD
Clevidipine—Tachycardia—Doxorubicin—testicular cancer	0.00032	0.00545	CcSEcCtD
Clevidipine—Dyspnoea—Epirubicin—testicular cancer	0.000316	0.00538	CcSEcCtD
Clevidipine—Hypotension—Doxorubicin—testicular cancer	0.000306	0.00522	CcSEcCtD
Clevidipine—Dyspnoea—Doxorubicin—testicular cancer	0.000292	0.00498	CcSEcCtD
Clevidipine—Hypersensitivity—Methotrexate—testicular cancer	0.000279	0.00475	CcSEcCtD
Clevidipine—Hypersensitivity—Epirubicin—testicular cancer	0.000261	0.00445	CcSEcCtD
Clevidipine—Hypersensitivity—Doxorubicin—testicular cancer	0.000241	0.00411	CcSEcCtD
Clevidipine—Vomiting—Methotrexate—testicular cancer	0.000241	0.0041	CcSEcCtD
Clevidipine—Headache—Methotrexate—testicular cancer	0.000237	0.00404	CcSEcCtD
Clevidipine—Vomiting—Epirubicin—testicular cancer	0.000225	0.00384	CcSEcCtD
Clevidipine—Nausea—Methotrexate—testicular cancer	0.000225	0.00383	CcSEcCtD
Clevidipine—Headache—Epirubicin—testicular cancer	0.000222	0.00378	CcSEcCtD
Clevidipine—Nausea—Epirubicin—testicular cancer	0.00021	0.00358	CcSEcCtD
Clevidipine—Vomiting—Doxorubicin—testicular cancer	0.000208	0.00355	CcSEcCtD
Clevidipine—Headache—Doxorubicin—testicular cancer	0.000205	0.0035	CcSEcCtD
Clevidipine—Nausea—Doxorubicin—testicular cancer	0.000195	0.00332	CcSEcCtD
